Morgan Stanley’s Defiance Daily Target 2X Long ORCL ETF ORCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-242
Closed -$12.5K 8574
2025
Q4
$12.5K Buy
242
+241
+24,100% +$20.4K ﹤0.01% 6835
2025
Q3
$80 Buy
+1
New +$109 ﹤0.01% 7730

Other funds holding ORCX

Morgan Stanley's ORCX Position: Q1 2026 in Review

Morgan Stanley sold out of Defiance Daily Target 2X Long ORCL ETF (ORCX) in Q1 2026, closing a stake of 242 shares — an estimated $12.5K sold.

Morgan Stanley first reported a position in ORCX in Q3 2025 and held it in 2 quarters. The position peaked at $12.5K in Q4 2025. 10 funds tracked by Wall St. Rank hold ORCX as of Q1 2026.

  • Morgan Stanley reported no remaining Defiance Daily Target 2X Long ORCL ETF position as of Q1 2026 after selling out during the quarter.
  • Morgan Stanley sold 242 Defiance Daily Target 2X Long ORCL ETF shares in Q1 2026, an estimated $12.5K.
  • Morgan Stanley first reported a position in Defiance Daily Target 2X Long ORCL ETF in Q3 2025 and held it in 2 quarters.
  • Morgan Stanley's Defiance Daily Target 2X Long ORCL ETF position peaked at $12.5K in Q4 2025.
  • 10 funds tracked by Wall St. Rank held Defiance Daily Target 2X Long ORCL ETF as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.